help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 60, No. 2 299-305
doi:10.1210/jcem-60-2-299
Copyright © 1985 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GILBEAU, P. M
Right arrow Articles by SMITH, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GILBEAU, P. M
Right arrow Articles by SMITH, C. G.

Opioid Effects on Plasma Concentrations of LuteinizingHormone and Prolactin in the Adult Male Rhesus Monkey*

PAMELA M GILBEAU{dagger}, RAMONA G ALMIREZ, JOHN W. HOLADAY and CAROL GRACE SMITH

Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 Bethesda, Maryland 20814
Division of Neuropsychiatry, Walter Reed Army Institute of Research Washington, D.C. 20307–5100

The role of endogenous opioid peptides (EOP)in the neuroendocrine control of primate gonadotropin and PRLsecretion was studied in nonrestrained adult male rhesus monkeys.Morphine (0.5β1.0 mg/kg) was used as the prototypeopiate, β-endorphin (β-END; 10-20 µg/kg) and [D-Ala2,D-Leu5]enkephalin (DADLE; 5β20 mg/kg) were used as representativesof EOP, and naloxone (0.5β2.0 mg/kg) was used as an opiatereceptor blocker. Drugs were administered and blood was collected(at 20-min intervals for 4 h) through an indwelling jugularcatheter. LH and PRL levels were measured in plasma by RIA.

Intravenous administration of morphine (1.0 µg/kg) and DADLE (10 g/kg) produced decreases in LH levels of 64% and40%, respectively. These decreases occurred within 1 h afterdrug injections and lasted for approximately 3 h. (β-END had noeffect on LH levels. Naloxone, at all doses studied, significantlyincreased LH levels (5- to 8-fold). The LH rises occurred within20 min and lasted for up to 2 h. Both morphine and β-END produced immediate increases in PRL, which remained elevatedfor 3 h. DADLE did not alter PRL levels. Naloxone (1.0 and 2.0mg/kg) decreased PRL concentrations (45% and 60%, respectively).

Pretreatment with morphine or DADLE did not alter the LHresponse to GnRH (100 µg) stimulation, indicating a hypothalamicsite of action for the opioid inhibition of LH release.Naloxone administration reversed the inhibitory effects of morphineand DADLE on LH. The stimulatory effect of morphineon PRL levels was also reversed by naloxone. These studiesfurther define the postulated physiological role of EOP in primatereproductive neuroendocrinology. Based on receptor selectivities of these opioid agonists, the inhibition of LH may bemediated by {Delta}-receptors, whereas PRL release appears to be µmediated.

* This work was supported by USUHS. Preliminary findings were reported in part at the American Society of Andrology, 1983 meeting.

{dagger} Present address: Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California 94143

Received June 27, 1984.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. W. Hill, J. K. Elmquist, and C. F. Elias
Hypothalamic pathways linking energy balance and reproduction
Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E827 - E832.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1985 by The Endocrine Society